| 10.89 0.09 (0.83%) | 04-17 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 13.18  |
1-year : | 15.4 |
| Resists | First : | 11.28 |
Second : | 13.18 |
| Pivot price | 10.89 |
|||
| Supports | First : | 10.5 |
Second : | 10.02 |
| MAs | MA(5) : | 10.84  |
MA(20) : | 10.95 |
| MA(100) : | 10.43 |
MA(250) : | 11.42 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 68.7 |
D(3) : | 68.9 |
| RSI | RSI(14): 49.6 |
|||
| 52-week | High : | 18.82 | Low : | 8.07 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ WBA ] has closed above bottom band by 49.2%. Bollinger Bands are 62.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 24 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 10.91 - 10.96 | 10.96 - 11.02 |
| Low: | 10.67 - 10.72 | 10.72 - 10.78 |
| Close: | 10.8 - 10.89 | 10.89 - 10.98 |
Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores. It also provides central specialty pharmacy services and mail services. As of August 31, 2021, this segment operated 8,965 retail stores under the Walgreens and Duane Reade brands in the United States; and five specialty pharmacies. The International segment sells prescription drugs; and health and wellness, beauty, personal care, and other consumer products through its pharmacy-led health and beauty retail stores and optical practices, as well as through boots.com and an integrated mobile application. It also engages in pharmaceutical wholesaling and distribution business in Germany. As of August 31, 2021, this segment operated 4,031 retail stores under the Boots, Benavides, and Ahumada in the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile; and 548 optical practices, including 160 on a franchise basis. Walgreens Boots Alliance, Inc. was founded in 1901 and is based in Deerfield, Illinois.
Thu, 17 Apr 2025
Walgreens Boots Alliance (WBA): Strong Industry, Solid Earnings Estimate Revisions - TradingView
Thu, 17 Apr 2025
Wells Fargo & Company MN Has $10.09 Million Stock Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) - Defense World
Tue, 15 Apr 2025
Walgreens: Acquisition Is The Best-Case Scenario For The Company - Seeking Alpha
Sun, 13 Apr 2025
Walgreens Comeback? Private Equity Circling for a Buyout - MarketBeat
Sat, 12 Apr 2025
Walgreens Boots Alliance (WBA) Exceeds Earnings and Revenue Expe - GuruFocus
Tue, 08 Apr 2025
Walgreens Posts Strong 4.1% Sales Growth as Pharmacy Sales Surge 8.9% - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Pharmaceuticals
|
|
| Shares Out | 865 (M) |
| Shares Float | 715 (M) |
| Held by Insiders | 17.4 (%) |
| Held by Institutions | 63.4 (%) |
| Shares Short | 45,950 (K) |
| Shares Short P.Month | 67,050 (K) |
| EPS | -10.24 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 11.51 |
| Profit Margin | -5.9 % |
| Operating Margin | -0.2 % |
| Return on Assets (ttm) | 0.5 % |
| Return on Equity (ttm) | -80.9 % |
| Qtrly Rev. Growth | 7.5 % |
| Gross Profit (p.s.) | 30.68 |
| Sales Per Share | 173.93 |
| EBITDA (p.s.) | 3.26 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 1,160 (M) |
| Levered Free Cash Flow | 4,330 (M) |
| PE Ratio | -1.07 |
| PEG Ratio | 0 |
| Price to Book value | 0.94 |
| Price to Sales | 0.06 |
| Price to Cash Flow | 8.11 |
| Dividend | 0.25 |
| Forward Dividend | 0 |
| Dividend Yield | 2.2% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|